Home | November 2014News | The most focused founder of neuroendocrine cancer research launches $2 million immunotherapy initiative |
|
|
The most focused founder of neuroendocrine cancer research launches $2 million immunotherapy initiative
- The most focused founder of neuroendocrine cancer research launches $2 million immunotherapy initiative
- November 12, 2014
-
After a year of reviewing the research, consulting with experts, and engaging leading immunotherapy centers, the Caring for Carcinoid Foundation is thrilled to announce the launch of a major immunotherapy initiative for neuroendocrine cancer. A treatment that uses the body's own immune system to fight cancer, immunotherapy has led to dramatic results for some patients with other forms of cancer.
Boston, MA - The Caring for Carcinoid Foundation, a non-profit that funds research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers, is embarking upon a major research initiative in immunotherapy. A treatment that uses the body's own immune system to fight cancer, immunotherapy has led to dramatic results for some patients with other forms of cancer. The Caring for Carcinoid Foundation is eager to test the potential of immune-based the...
- View more at: http://www.1888pressrelease.com/neuroendocrine-cancer/immunotherapy/the-most-focused-founder-of-neuroendocrine-cancer-research-l-pr-547138.html
|